BioSpace News Archive

Pharm Country

Computer Game May Help to Predict Reuse of Opioids

A computer betting game can help predict the likelihood that someone recovering from opioid addiction will reuse the pain-relieving drugs, a new study shows.

December 8, 2019
·
4 min read
Results from a Survey With Patients With Immune Thrombocytopenia (ITP) Demonstrates Disease Burden and Impact for Patients With ITP

Dova Pharmaceuticals, a wholly owned subsidiary of Swedish Orphan Biovitrum AB, presented results from an online survey highlighting disease burden and impact for patients with immune thrombocytopenia, at the 61st Annual Meeting of the American Society of Hematology taking place in Orlando, 7-10 December.

December 8, 2019
·
3 min read
Drug Development

Agios Establishes Proof-of-Concept for Mitapivat in Non-transfusion-dependent Thalassemia Based on Preliminary Phase 2 Results

Treatment with Mitapivat Induced Hemoglobin Increase of ≥1.0 g/dL in 7 of 8 Evaluable Patients

December 8, 2019
·
6 min read
Drug Development

Oncopeptides Presents Promising Data from the Phase 2 ANCHOR Combination Study in Patients With RRMM at ASH Annual Meeting 2019

Oncopeptides AB will present updated data from the ongoing Phase 2 ANCHOR triple combination study at the ASH Annual Meeting 2019.

December 8, 2019
·
5 min read
Drug Development

Stoke Therapeutics Presents Preclinical Data on the Biodistribution, Target Engagement and Safety of STK-001 in Non-Human Primates That Support the Planned Clinical Development of STK-001 for the Treatment of Dravet Syndrome

STK-001 showed distribution throughout the brain after a single intrathecal injection; Target engagement and increased Nav1.1 protein expression were observed throughout the cortex

December 8, 2019
·
8 min read
Drug Development

Portola Pharmaceuticals Presents New Interim Data from Ongoing Phase 2a Study of its Oral SYK/JAK Inhibitor Cerdulatinib in Heavily Pre-Treated T-Cell Malignancies

Interim Results Demonstrate Good Tolerability and Clinical Response in Patients with Relapsed/Refractory PTCL and CTCL

December 8, 2019
·
6 min read
Business

Company Profile for Jasper Therapeutics, Inc

Jasper Therapeutics is a biotechnology company focused on enabling safer conditioning agents and therapeutics to allow for expanded use of curative hematopoietic stem cell transplants and gene therapies.

December 8, 2019
·
1 min read
Lilly Presents Interim Clinical Data from LOXO-305 Dose Escalation Trial in B-Cell Leukemias and Lymphomas at the American Society Hematology Annual Meeting

Responses observed at all dose levels in Chronic Lymphocytic Leukemia (CLL) and Mantle Cell Lymphoma (MCL), including patients with BTK Resistance, BTK Intolerance, and BCL2 Resistance

December 8, 2019
·
9 min read
Genetown

BeiGene Announces Clinical Data on BRUKINSA™ (Zanubrutinib) at the 61st American Society of Hematology (ASH) Annual Meeting

Oral presentations on data from two clinical trials in chronic lymphocytic leukemia or small lymphocytic lymphoma

December 8, 2019
·
16 min read
Drug Development

Rocket Pharmaceuticals Presents Promising Preliminary Results from Phase 1 Trial of Commercial-Grade RP-L102 “Process B” for Fanconi Anemia at 61st American Society of Hematology Annual Meeting

US Phase 1 Trial Establishes Feasibility of Commercial “Process B” Vector/Cell Manufacturing in FA

December 8, 2019
·
8 min read